GE buys Image Diagnost International
- 13 February 2008
GE Healthcare has acquired German based Image Diagnost International, a provider of IT systems used in the diagnosis of breast cancer.
GE says that Image Diagnost’s software offering will expand its capabilities in breast cancer detection, offering clinicians and national screening services one of the most comprehensive ranges of systems available.
David Caumartin, general manager of GE Healthcare’s mammography business, said: “Image Diagnost and GE Healthcare have a shared vision on how best to accelerate the adoption of digital mammography and to harness the benefits that the new technology brings to the diagnosis and detection of breast cancer.”
Image Diagnost develops integrated software solutions for mammography workflow and image processing, used in over 150 locations across Germany. The company has recently filed for US FDA approval for its MammoWorkstation system.
GE Healthcare believe that as the number of hospitals, clinics and screening services using their digital mammography increases, customers will also want Image Diagnost’s integrated software solutions to facilitate reporting, storage, sharing and transmission of mammography data.
Caumartin said: “The combination of GE Healthcare’s skills in the development of imaging equipment together with the expertise of the team at Image Diagnost is a major step forward in assisting hospitals worldwide to use digital mammography to its full potential. Expanding GE Healthcare’s expertise in this area supports our early health objective of developing tools to help doctors diagnose and treat disease earlier.”
Image Diagnost’s head office in Munich, Germany, will now become a GE Healthcare centre of excellence in breast cancer detection software.
Dr Wilfried Schneider, founder of Image Diagnost, said: “The additional resources that GE Healthcare brings will allow us to accelerate our development programs and bring our products to a much wider customer base. The combination of the two companies will bring substantial benefits to hospitals, screening services and women’s healthcare worldwide.”
Link
